Final FDA Type C Meeting December 11, 2025 - biomarker data to be available October 10, 2025 FDA/Osteosarcoma Institute Workshop narrows focus for OST-HER2 overall survival, biomarker correlation & ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback